Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 373 for

Edit search filters
  1. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

    Rochester, MN

  2. A Study of Using Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

    Rochester, MN

  3. Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD

    Rochester, MN

  4. Reducing Smoke Exposure in Children Facing Surgery

    Rochester, MN

  5. A Study of Repetitive Transcranial Magnetic Stimulation as a Treatment for Depression Added to Standard Care

    Rochester, MN

  6. Trial of Overminus Spectacle Therapy for Intermittent Exotropia

    Rochester, MN

  7. A Study of Immune Response to the Human Papillomavirus Vaccine in Young Women with Inflammatory Bowel Disease

    Rochester, MN

  8. A Study of Intrathecal SHP611 in Participants With Late Infantile Metachromatic Leukodystrophy

  9. A Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients with Rare Epilepsy

    Rochester, MN

  10. A Study of Characteristics and Post-surgical Outcomes of Pediatric Patients Diagnosed with Lipoblastoma

    Rochester, MN

.

Mayo Clinic Footer